Alzheimer’s Amyloid-Clearing Monoclonal Antibody Drug Lecanemab Shows Positive Results, Poised for FDA Approval
Summary: Lecanemab, an amyloid-clearing monoclonal antibody drug exhibits constructive leads to the remedy of Alzheimer’s illness. The drug is now ...